Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study

Authors

Institutions

Publication Details

Journal
Arthritis Research & Therapy
Published
2025-04-17
DOI
https://doi.org/10.1186/s13075-025-03555-2
Citations
3
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
5.31
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study

Naoto Azuma, Takeo ABE, Akira Hashiramoto, Y. Terashima et al.
3 citations
Arthritis Research & Therapy
Autoimmune and Inflammatory Disorders Research
5.31
article

Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study

Naoto Azuma, Takeo ABE, Akira Hashiramoto, Y. Terashima, Kazuteru Noguchi, Kiyoshi Matsui, Teppei Hashimoto, Kazuyuki Tsuboi, Tetsuya Furukawa, Takashi Yamane, Takahiro Yoshikawa, Koji Tateishi, Nao Sibanuma
article en
3 citations

Abstract

No abstract available for this paper.
Arthritis Research & TherapyVol. 27(1)
Kobe Kaisei Hospital (JP), Hirosaki Central Hospital (JP), Kagawa University Hospital (JP), Kobe City Medical Center West Hospital (JP), Edogawa Hospital (JP), Kagawa Prefectural Central Hospital (JP)
Good health and well-being
Openalex Percentile: Top 5%
Autoimmune and Inflammatory Disorders Research
5.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Nocturnal baricitinib administration leads to rapid drug responses in rheumatoid arthritis: a multicenter non-randomized controlled study — Naoto Azuma, Takeo ABE, et al. · Arthritis Research & Therapy (2025) | TGRS Research Map | TGRS